Skip to main content
Premium Trial:

Request an Annual Quote

Ben Bulkley, John Radak, Bernd Brust, Kelli Richard, David Wellis

Premium
Invitrogen last week said in an SEC filing that Ben Bulkley, its senior vice president of commercial operations, and John Radak, its finance and principal accounting officer, will leave the company at the end of January.
 
Bulkley will be replaced by Bernd Brust, Invitrogen’s general manager and vice president of European operations. Brust will be responsible for sales strategies, customer relations, and identifying avenues for customer growth, the company said.
 
Radak will be replaced by Kelli Richard, who has served as corporate controller at Invitrogen and as vice president and controller at Gateway.
 
David Wellis was appointed CEO of DNA sample storage company GenVault in mid-December, the company said last week.
 
Before coming to GenVault Wellis was vice president of functional genomics at Axon Instruments.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.